Skip to Main Content

Author Details

Stefan Hartmann
University Hospital Wurzburg
2013
64
14
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36435082A liquid chromatography-tandem mass spectrometry method for the quantification of ampicillin/sulbactam and clindamycin in jawbone, plasma, and platelet-rich fibrin: Application to patients with osteonecrosis of the jaw.J Pharm Biomed Anal2023
37685806Comprehensive Geriatric Assessment and Quality of Life Aspects in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC).J Clin Med2023
37603167Investigation of three common centrifugation protocols for platelet-rich fibrin (PRF) as a bio-carrier for ampicillin/sulbactam: a prospective trial.Clin Oral Investig2023
36980719Adjuvant Radiotherapy in Patients with Squamous Cell Carcinoma of the Oral Cavity or Oropharynx and Solitary Ipsilateral Lymph Node Metastasis (pN1)-A Prospective Multicentric Cohort Study.Cancers (Basel)2023
37367038Metabolic Silencing via Methionine-Based Amino Acid Restriction in Head and Neck Cancer.Curr Issues Mol Biol2023
35054968PKM2 Modulation in Head and Neck Squamous Cell Carcinoma.Int J Mol Sci2022
35741216Artificial Intelligence-Based Prediction of Oroantral Communication after Tooth Extraction Utilizing Preoperative Panoramic Radiography.Diagnostics (Basel)2022
35794029[<sup>18</sup>F]FDG-PET/CT improves the detection of synchronous malignancies at primary staging of oral squamous cell carcinoma - A retrospective study.J Craniomaxillofac Surg2022
35743574Free Skin Grafting to Reconstruct Donor Sites after Radial Forearm Flap Harvesting: A Prospective Study with Platelet-Rich Fibrin (PRF).J Clin Med2022
36429636Bone Concentration of Ampicillin/Sulbactam: A Pilot Study in Patients with Osteonecrosis of the Jaw.Int J Environ Res Public Health2022
36460690Using a 3D asymmetry index as a novel form for capturing complex three-dimensionality in positional plagiocephaly.Sci Rep2022
36498784Associations between Periodontitis and COPD: An Artificial Intelligence-Based Analysis of NHANES III.J Clin Med2022
35941396Evaluation of advanced platelet-rich fibrin (PRF) as a bio-carrier for ampicillin/sulbactam.Clin Oral Investig2022
36141982Oral-Health-Related Quality of Life in Patients with Medication-Related Osteonecrosis of the Jaw: A Prospective Clinical Study.Int J Environ Res Public Health2022
36052496Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.Cancer Res2022
36052495Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.Cancer Res2022
36012485Mass Spectrometric Metabolic Fingerprinting of 2-Deoxy-D-Glucose (2-DG)-Induced Inhibition of Glycolysis and Comparative Analysis of Methionine Restriction versus Glucose Restriction under Perfusion Culture in the Murine L929 Model System.Int J Mol Sci2022
35159360Low Energy Status under Methionine Restriction Is Essentially Independent of Proliferation or Cell Contact Inhibition.Cells2022
34050405Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [<sup>18</sup>F]FDG PET/CT and MRI.Eur J Nucl Med Mol Imaging2021
33881529Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.JAMA Netw Open2021
34650798Mammary analogue secretory carcinoma of a salivary gland of the hard palate with contralateral cervical lymph node metastases: A case report.Mol Clin Oncol2021
34210565Validation of the German-language version of the Liverpool Oral Rehabilitation Questionnaire version 3 and evaluation of oral-health-related quality of life among patients with squamous cell carcinoma of the head and neck.J Craniomaxillofac Surg2021
34261774Correction: Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> Patients.Clin Cancer Res2021
30796524Osteoporosis therapy in patients with inflammatory rheumatic diseases and osteonecrosis of the jaw.Z Rheumatol2020
31940827The Influence of Met Receptor Level on HGF-Induced Glycolytic Reprogramming in Head and Neck Squamous Cell Carcinoma.Int J Mol Sci2020
33233528HGF-Induced PD-L1 Expression in Head and Neck Cancer: Preclinical and Clinical Findings.Int J Mol Sci2020
32507671Sensitization of head and neck squamous cell carcinoma to apoptosis by combinational SMAC mimetic and Fas ligand-Fc treatment in vitro.J Craniomaxillofac Surg2020
30875877The Selection of NFκB Inhibitors to Block Inflammation and Induce Sensitisation to FasL-Induced Apoptosis in HNSCC Cell Lines Is Critical for Their Use as a Prospective Cancer Therapy.Int J Mol Sci2019
31387829Targeting inhibitors of apoptosis in oral squamous cell carcinoma in vitro.J Craniomaxillofac Surg2019
31452723Multi-kinase inhibitors and cisplatin for head and neck cancer treatment <i>in vitro</i>.Oncol Lett2019
30709758MicroRNA expression correlates with disease recurrence and overall survival in oral squamous cell carcinoma.J Craniomaxillofac Surg2019
30709394Medical-grade polycaprolactone scaffolds made by melt electrospinning writing for oral bone regeneration - a pilot study in vitro.BMC Oral Health2019
30826113A new multilayered membrane for tissue engineering of oral hard- and soft tissue by means of melt electrospinning writing and film casting - An in vitro study.J Craniomaxillofac Surg2019
29034444MAGE-A11 expression contributes to cisplatin resistance in head and neck cancer.Clin Oral Investig2018
29467909Apoptosis-sensitizing activity of birinapant in head and neck squamous cell carcinoma cell lines.Oncol Lett2018
29440171Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.Cancer Res2018
29459186Squamous cell carcinoma of the maxilla: Analysis of clinicopathological predictors for disease recurrence and metastatic behavior.J Craniomaxillofac Surg2018
29556384MAGE-A9 in head and neck cancer: Prognostic value and preclinical findings in the context of irradiation.Mol Clin Oncol2018
29311018Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancer.J Craniomaxillofac Surg2018
27631596The prognostic value of GLUT-1 staining in the detection of malignant transformation in oral mucosa.Clin Oral Investig2017
29246276Nutrition management for head and neck cancer patients improves clinical outcome and survival.Nutr Res2017
28762116Merkel Cell Carcinoma of the Head and Neck: Recommendations for Diagnostics and Treatment.Ann Surg Oncol2017
28714017Targeting VEGFR and FGFR in head and neck squamous cell carcinoma in vitro.Oncol Rep2017
27986750Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> Patients.Clin Cancer Res2017
26782932Co-treatment of wild-type EGFR head and neck cancer cell lines with afatinib and cisplatin.Mol Med Rep2016
26245271Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas.Clin Oral Investig2016
26297130Erlotinib and gefitinib responsiveness in head and neck cancer cell lines--a comparing analysis with cetuximab.Clin Oral Investig2016
27703530Contrary melanoma-associated antigen-A expression at the tumor front and center: A comparative analysis of stage I and IV head and neck squamous cell carcinoma.Oncol Lett2016
27643444Treatment of head and neck cancer in the elderly.Expert Opin Pharmacother2016
27680099Mandibular intraosseous pseudocarcinomatous hyperplasia: a case report.J Med Case Rep2016
  • 1 - 50 of 64

Recommended Authors

Stefano Cavalieri
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, University of Milan
Career Start Year 2016
Number of shared co-authors 0
Neil Mundi
Southern Illinois University School of Medicine
Career Start Year 2013
Number of shared co-authors 0
Takahito Fukusumi
Osaka University Graduate School of Medicine
Career Start Year 2012
Number of shared co-authors 0
Zhiyong Wang
Moores Cancer Center, University of California San Diego
Career Start Year 2008
Number of shared co-authors 9
Myung Woul Han
Ulsan University Hospital, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 0
Mizuo Ando
University of Tokyo
Career Start Year 2005
Number of shared co-authors 0
Sabrina Daniela da Silva
Jewish General Hospital
Career Start Year 2004
Number of shared co-authors 0
Kathrin Scheckenbach
Heinrich-Heine University
Career Start Year 2002
Number of shared co-authors 0
Akihiro Sakai
Tokai University
Career Start Year 2002
Number of shared co-authors 0
Anthony C Nichols
University of Western Ontario
Career Start Year 2001
Number of shared co-authors 1
Ezra E W Cohen
university of california san diego Health System
Career Start Year 2001
Number of shared co-authors 4
Robert I Haddad
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2001
Number of shared co-authors 2
Hyunseok Kang
Johns Hopkins University
Career Start Year 2000
Number of shared co-authors 5
Rifat Hasina
University of Chicago Medicine
Career Start Year 1999
Number of shared co-authors 1
Richard J Wong
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 1
Patrick K Ha
University of California San Francisco
Career Start Year 1998
Number of shared co-authors 10
Yorihisa Imanishi
International University of Health and Welfare, Narita Hospital
Career Start Year 1996
Number of shared co-authors 0
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 1
Mark W Lingen
University of Chicago Pritzker School of Medicine
Career Start Year 1993
Number of shared co-authors 2
Bhuvanesh Singh
Memorial Sloan Kettering Cancer Center
Career Start Year 1991
Number of shared co-authors 0
Charles R Leemans
Location Vrije Universiteit Amsterdam
Career Start Year 1990
Number of shared co-authors 4
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 0
Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 2
Ravindra Uppaluri
Brigham and Women's Hospital
Career Start Year 1988
Number of shared co-authors 2
Wayne M Koch
Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 2
Lisa Licitra
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Career Start Year 1987
Number of shared co-authors 0
David G Pfister
Memorial Sloan Kettering Cancer Center
Career Start Year 1987
Number of shared co-authors 1
Ruud H Brakenhoff
Vrije Universiteit Amsterdam
Career Start Year 1986
Number of shared co-authors 0
Wendell G Yarbrough
University of North Carolina at Chapel Hill
Career Start Year 1986
Number of shared co-authors 3
Carter Van Waes
National Institute of Deafness and Other Communication Disorders
Career Start Year 1984
Number of shared co-authors 0

Collaborators

Jennifer R Grandis
University of California san francisco
Co-authored papers 7
Neil E Bhola
Zai Lab (US) LLC
Co-authored papers 6
Theresa M LaVallee
Parker Institute for Cancer Immunotherapy
Co-authored papers 5
Toni M Brand
University of Wisconsin School of Medicine and Public Health
Co-authored papers 5
Umamaheswar Duvvuri
University of Pittsburgh School of Medicine
Co-authored papers 5
Daniel E Johnson
University of California San Francisco
Co-authored papers 5
Max V Ranall
University of California San Francisco
Co-authored papers 5
Yan Zeng
Department of Pharmacy, Affiliated Hospital of North Sichuan Medical College
Co-authored papers 5
Sourav Bandyopadhyay
University of California San Francisco
Co-authored papers 5
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 3
Michelle A Ozbun
The University of New Mexico School of Medicine
Co-authored papers 3
Carolyn Kemp
University of Pittsburgh Medical Center, Eye and Ear Institute
Co-authored papers 3
Julie E Bauman
George Washington University
Co-authored papers 3
Rachel A O'Keefe
University of California San Francisco
Co-authored papers 3
Hua Li
University of California san francisco
Co-authored papers 3
Margaret Soucheray
J. David Gladstone Institutes
Co-authored papers 3
Release 1.2